About RegenEra Ventures
RegenEra Ventures is a global VC fund focusing on early-stage biotech companies in the field of regenerative medicine and diseases of ageing. Founded in 2025, we combine a strong industry network with an experienced investment team and scientific expertise.
Our Mission
RegenEra bridges the gap between innovative research and clinical validation in regenerative and geromedicine.
Our Focus
We operate globally with primary focus on Europe as a lead/co-lead investor for Seed to Series A companies with a science-driven approach.
Our Team
General Partners
Patrick Burgermeister
General Partner
Masters in Molecular Biology and Economics, CFA
• Former partner @BioMedInvest (CHF 350mio in three funds) and Kizoo (15 investments in the longevity biotech space)
• Exits include 6 IPOs, and trade sales to Baxter, Boehringer, GSK, Novartis, Roche
• Trade sale of Okairos (lead investor and CFO)
General Partner
PhD in Biochemistry
• Ph.D. in Biochemistry from Max-Planck Institute and prior experience at institutions like Epidarex Capital, Kymab, AstraZeneca
• Seasoned life science investor & executive with deep expertise across VC, company building and R&D
• Senior roles in investment & operational capacities, contributing to the success of early-stage biotech companies in Europe & US
• Strong scientific background combined with hands-on experience in deal sourcing, DD and strategic execution
• Served on several boards and passionate about translating breakthrough science into transformative healthcare solutions
Scientific Advisors
Guido Kroemer
Ageing Biology
World-renowned ageing professor with extensive expertise in cellular aging mechanisms and longevity research.
Alejandro Ocampo
Reprogramming
Pioneer in cellular reprogramming with groundbreaking research in aging and regenerative medicine.
James B. Summers
Neuroscience
Industry veteran with 30+ years in neuroscience and extensive experience in drug development.
Oxana Polyakova
Cell therapy
Industry expert in cellular therapies with deep expertise in immunological interventions.
Richard Sainson
Immunology
Industry expert in immunology with extensive experience in therapeutic development.
Melanie Lee
Strategy
Nigel Clark
Business Development
Laura Millichamp
Regulatory
Investment Focus
RegenEra bridges the gap between innovative research and clinical validation in regenerative and geromedicine.
Cardiometabolic
Targeting cardiovascular and metabolic diseases through innovative therapeutic approaches and biomarker development.
Neurodegenerative
Advancing treatments for Alzheimer's, Parkinson's, and other neurodegenerative conditions through cutting-edge research.
Immunology/Inflammation
Developing immunomodulatory therapies and anti-inflammatory treatments for age-related immune dysfunction.
Market Opportunity
Diseases of ageing are driven by demographic shifts and our advancing scientific understanding of the aging processes. This convergence creates unprecedented investment opportunities as global populations age and demand for age-related disease solutions accelerates.
Invest in the Future of Healthspan
Healthspan innovation is reshaping the future of healthcare—impacting every facet of life and unlocking unprecedented investment potential. As global populations age, the demand for solutions to chronic, degenerative diseases is accelerating. At the same time, breakthroughs in the biology of ageing are driving a fundamental shift: from treating individual symptoms to targeting the root cause of decline.
Addressing the biology of ageing offers a more scalable and durable return profile than single- disease approaches. The healthspan market is projected to reach $367 billion by 2032, growing at over 30% annually, as scientific and commercial momentum builds.
RegenEra Ventures is at the forefront of this revolution—backing visionary founders advancing the future of regenerative medicine and tackling diseases of ageing. We partner with forward-thinking investors who share our commitment to transforming how the world ages— scientifically, socially, and economically.
For further information on investment opportunities, please reach out to us:
investors@regeneravc.comNews & Events
Upcoming Events
Stay tuned for announcements about upcoming conferences, webinars, and industry events where RegenEra Ventures will be participating.
Past Presentations
Access our previous presentations, interviews, and thought leadership content on regenerative medicine and healthspan investing.
For media inquiries or speaking opportunities, please contact us:
info@regeneravc.comContact Us
We're interested in speaking with founders and researchers in regenerative medicine targeting diseases of ageing.